Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer’s disease

Robert A Rissman · 2025

Read Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer’s disease by Robert A Rissman (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710425.txt.

Description

Robert Rissman reports 2025 findings on blood tests that sort people by brain amyloid in preclinical Alzheimer's disease. A plasma ratio test for amyloid can predict raised brain amyloid on PET scans, and the team asked if adding tau measures makes that call sharper.

Samples came from more than a thousand people screening for a preclinical trial. Mass spectrometry measured amyloid and two forms of phosphorylated tau in plasma. Adding the phospho-tau217 ratio in particular lifted how well the blood test matched PET class. That gain could cut the cost and load of trial screening.

Catalog record

CREATORRobert A Rissman
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11710425

Browse the full library · About the Tower of Babel